Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

Полное описание

Библиографические подробности
Главные авторы:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
Формат:	Journal article
Язык:	English
Опубликовано:	Springer Nature 2020

Схожие документы

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
по: Yasunori Watanabe, и др.
Опубликовано: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
по: Watanabe, Y, и др.
Опубликовано: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
по: Crispin, M, и др.
Опубликовано: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
по: Crispin, M, и др.
Опубликовано: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
по: Seabright, GE
Опубликовано: (2019)

Beyond Shielding: The Roles of Glycans in the SARS-CoV‑2 Spike Protein
по: Lorenzo Casalino, и др.
Опубликовано: (2020-09-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
по: Pritchard, L, и др.
Опубликовано: (2015)

Architecture of the HIV-1 glycan shield
по: Pritchard, L
Опубликовано: (2014)

Mapping the glycan shields of enveloped viruses
по: Watanabe, Y
Опубликовано: (2020)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
по: Behrens, AJ, и др.
Опубликовано: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
по: Joel D. Allen, и др.
Опубликовано: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
по: Bonomelli, C, и др.
Опубликовано: (2011)

Glycosylator: a Python framework for the rapid modeling of glycans
по: Thomas Lemmin, и др.
Опубликовано: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
по: Amr Sobhi Gouda, и др.
Опубликовано: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
по: Le, N, и др.
Опубликовано: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
по: Camille Bonomelli, и др.
Опубликовано: (2011-01-01)

Fine structure of the HIV-1 glycan shield
по: Behrens, A
Опубликовано: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
по: Weiwei Peng, и др.
Опубликовано: (2022-08-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
по: Mingjun Yang, и др.
Опубликовано: (2017-06-01)

Glycan Nanostructures of Human Coronaviruses
по: Guo W, и др.
Опубликовано: (2021-07-01)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
по: Sommerstein, R, и др.
Опубликовано: (2015)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
по: Rami Sommerstein, и др.
Опубликовано: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
по: Rising, T, и др.
Опубликовано: (2006)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
по: Parham Jabbarzadeh Kaboli, и др.
Опубликовано: (2025-02-01)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
по: Mihaela-Olivia Dobrica, и др.
Опубликовано: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
по: Marie-Estelle Losfeld, и др.
Опубликовано: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
по: Julien J, и др.
Опубликовано: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
по: Qing Wei, и др.
Опубликовано: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
по: Bénédicte Machiels, и др.
Опубликовано: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
по: Esteban Cruz, и др.
Опубликовано: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
по: Naveen Vankadari, и др.
Опубликовано: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
по: Pejchal, R, и др.
Опубликовано: (2011)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
по: Jonathan J Lyons, и др.
Опубликовано: (2015-06-01)

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
по: Ruofan Li, и др.
Опубликовано: (2024-10-01)

Fine structure of the HIV-1 glycan shield - Supplementary information
по: Behrens, A
Опубликовано: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
по: Tongqing Zhou, и др.
Опубликовано: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
по: Muriel Lavie, и др.
Опубликовано: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
по: Pritchard, L, и др.
Опубликовано: (2015)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
по: Rajesh P Ringe, и др.
Опубликовано: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
по: Davis, B, и др.
Опубликовано: (2000)